XML 43 R32.htm IDEA: XBRL DOCUMENT v3.23.3
GOODWILL AND INTANGIBLE ASSETS (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Finite-Lived Intangible Assets [Line Items]          
Intangible Assets, Gross (Excluding Goodwill) $ 4,906.4   $ 4,906.4   $ 4,593.2
Goodwill 6,331.9   6,331.9   6,123.7
Amortization of intangibles and other assets 55.7 $ 49.0 160.6 $ 149.0  
Adjustments to goodwill     (22.3)    
Estimated amortization expense, 2012 57.0   57.0    
Estimated amortization expense, 2013 228.0   228.0    
Estimated amortization expense, 2014 218.2   218.2    
Estimated amortization expense, 2015 209.3   209.3    
Estimated amortization expense, 2016 198.1   198.1    
Estimated amortization expense, Thereafter 1,784.0   1,784.0    
Current Expected Credit Losses Opening Balance Sheet Impact on Retained Earnings     6.2    
Amortization of intangible assets 55.7 $ 49.0 160.6 $ 149.0  
Early Development          
Finite-Lived Intangible Assets [Line Items]          
Reporting Unit, Amount of Fair Value in Excess of Carrying Amount         0.0
LabCorp Diagnostics [Member]          
Finite-Lived Intangible Assets [Line Items]          
Goodwill 4,745.4   4,745.4   4,533.5
Adjustments to goodwill     (18.6)    
Covance Drug Development [Member]          
Finite-Lived Intangible Assets [Line Items]          
Goodwill $ 1,586.5   1,586.5   $ 1,590.2
Adjustments to goodwill     $ (3.7)